Our Posts

Boston Scientific allegedly used counterfeit plastic in their vaginal mesh products, leading to medical complications. After Chevron Phillips stopped supplying Marlex, the FDA-approved plastic for these implants, Boston Scientific sought new sources. They discreetly acquired a product from China, which tests later revealed was not genuine Marlex. Despite this, they used it in implants, resulting in devices that shrank and dissolved in patients' bodies. This led to significant medical issues and mass litigation, the largest since asbestos claims.

New evidence suggests that proton pump inhibitors (PPIs), commonly used to treat conditions like GERD and ulcers, may increase the risk of Clostridium difficile-associated diarrhea (CDAD). A study from Saint Joseph Regional Medical Center in Indiana found a correlation between increased PPI use and rising CDAD cases, similar to patterns observed with antibiotic use. Concerns about PPI overuse and misuse are growing, as many prescriptions are for inappropriate indications. PPIs are intended for short-term use, but many patients take them longer than recommended, potentially leading to other health risks.

Lawsuits are being filed against Abbott Laboratories due to failures in the Heartmate 3 left ventricular assist system, linked to graft occlusion and severe risks. Parker Waichman LLP represents clients nationwide, seeking compensation for injuries caused by the device. The Heartmate 3, used for heart failure support, was recalled by the FDA in 2018 due to design flaws causing blood flow blockages. Victims are advised to consult attorneys to pursue claims and secure compensation for medical expenses and suffering. Parker Waichman offers contingency-based legal services to assist affected individuals.

The FDA has mandated stronger warning labels for certain proton pump inhibitors (PPIs) used to treat heartburn, such as Nexium and Protonix, following a petition by Public Citizen. These labels will now include warnings about antibiotic-associated diarrhea and drug interactions. However, the FDA did not require Black Box warnings, as the adverse effects were not deemed severe enough. Public Citizen criticized the FDA for delaying action, noting the widespread use of PPIs and the potential risks involved.

Court documents reveal nearly 7,000 lawsuits filed in Texas district court as part of the multidistrict litigation concerning DePuy Orthopaedics’ Pinnacle hip implants. Plaintiffs claim DePuy, a Johnson & Johnson subsidiary, failed to warn about potential implant failures due to defective design. The FDA noted metal-on-metal hips could release metal particles, causing complications like metallosis. DePuy stopped selling these implants in 2013. The first trial began on September 3, with a Montana woman seeking damages for injuries and emotional distress. Judge James E. Kinkeade oversees the trial, maintaining jurisdiction in Texas.

Bayer is facing numerous lawsuits over its Essure female sterilization device, with plaintiffs alleging injuries such as immune responses, allergic reactions, chronic pain, and unintended pregnancies. The lawsuits claim Bayer failed to adequately warn about these risks. Complaints have surged, prompting a label update and further FDA scrutiny. Essure, approved in 2002, has been linked to various adverse events, leading to calls for more research and legal actions. Some clinical trial participants also allege inaccuracies in data recording, raising concerns about the device's safety profile.

Parker Waichman LLP is investigating cases involving defective lithium batteries in St. Jude implantable cardioverter defibrillators (ICDs). These faulty batteries can cause the devices to shut down, posing serious health risks. The firm is pursuing a class action lawsuit against St. Jude and Abbott Laboratories, alleging they were aware of the defects but failed to inform the public. Individuals affected by these defective ICD batteries are encouraged to contact Parker Waichman LLP for a free consultation to determine eligibility to join the lawsuit.

Johnson & Johnson faced numerous lawsuits over the DePuy ASR hip implants, which were recalled due to high failure rates and complications. In 2012, J&J settled three lawsuits for $600,000 and later agreed to a $4 billion settlement for thousands of claims. The all-metal implants, intended for durability, caused issues like metal particles entering the bloodstream, leading to pain, infections, and revision surgeries. Patients who had revision surgery after March 2015 should verify their eligibility for compensation.

A lawsuit claims that Janssen Pharmaceuticals and Bayer Healthcare failed to warn about the risks of Xarelto, an anticoagulant linked to fatal bleeding. The suit alleges that Xarelto was marketed as superior to warfarin, despite lacking an antidote for excessive bleeding. Over 2,800 lawsuits have been consolidated in a federal multidistrict litigation in Louisiana, with additional cases in Philadelphia. Concerns were raised about the ROCKET-AF trials due to a faulty device affecting warfarin readings, potentially skewing results in favor of Xarelto.

A wrongful death lawsuit has been filed against Janssen Pharmaceuticals, Johnson & Johnson, and Bayer Healthcare over the anticoagulant Xarelto. The lawsuit, filed on behalf of a West Virginia man who died allegedly due to Xarelto side effects, accuses the companies of failing to disclose the drug's risks. The plaintiff experienced severe health issues, including bleeding in the lungs and septic shock, leading to his death in March 2015. The lawsuit seeks compensation for damages on behalf of the deceased's wife. Numerous similar lawsuits have been filed, alleging uncontrollable bleeding and lack of an antidote.

Parker Waichman LLP is reviewing claims related to fatalities associated with Hemlibra, a hemophilia drug by Genentech, a Roche subsidiary. Five deaths have been reported among patients using Hemlibra, which was approved by the FDA in 2017. Genentech maintains that these deaths were not caused by the drug. Hemlibra has a Black Box warning due to serious adverse events, including thrombotic microangiopathy. Roche's shares fell following the news of these deaths. Parker Waichman LLP offers free consultations for affected families.

Transvaginal mesh devices, used for pelvic organ prolapse and stress urinary incontinence, have faced significant safety concerns. Many women report worsened conditions, including pain and scarring. The FDA reclassified these devices as high-risk in 2016, requiring stricter testing. Johnson & Johnson's Ethicon unit ceased selling certain mesh products in 2012, citing commercial reasons. Numerous lawsuits have been filed, with settlements reaching millions. Complications include mesh erosion, organ damage, and chronic pain, often necessitating multiple surgeries. Legal actions continue against various manufacturers for these issues.

Individuals affected by benzocaine products, which can cause methemoglobinemia, may be eligible for compensation. The FDA has warned against using these products in young children due to severe health risks. Parker Waichman LLP represents clients in lawsuits against manufacturers for injuries and fatalities linked to benzocaine. Victims can seek damages for medical costs, economic losses, and suffering. The firm offers free consultations and operates on a contingency fee basis, urging timely action to meet legal deadlines.

In 2017, four bellwether trials for Xarelto were scheduled as part of MDL 2592, involving over 2,800 lawsuits against Bayer AG and Janssen Pharmaceuticals. These trials, overseen by U.S. District Judge Eldon E. Fallon, aim to address claims that the companies failed to warn about the risk of irreversible bleeding associated with Xarelto. The trial dates are February 6, March 13, April 24, and May 30, 2017. The first two trials will occur in Louisiana, with locations for the others tentatively set for Mississippi and Texas.

The trial involving DePuy Orthopaedics' metal-on-metal hip implants is under investigation by the U.S. Attorney’s Office and the FBI due to allegations of witness tampering. The implants, marketed as durable alternatives for active patients, have caused health issues like high metal levels in the blood and tissue poisoning. Concerns arose when a DePuy sales representative allegedly warned a witness about potential repercussions for testifying. Plaintiff’s attorney Mark Lanier reported this to the court, leading to an investigation. DePuy’s attorneys deny any misconduct, while the judge found the situation troubling.

A new lawsuit has been filed against Johnson & Johnson in the U.S. District Court for the Northern District of California. The plaintiff claims that using J&J's Baby Powder and Shower to Shower products for years led to her uterine cancer diagnosis in 2006. She alleges that J&J failed to warn consumers about the cancer risks associated with talc-based products, despite studies suggesting a link to ovarian cancer. Over 1,200 similar lawsuits are pending, accusing J&J of downplaying these risks.

Parker Waichman LLP offers free consultations for potential Bair Hugger cases, investigating claims with no upfront costs. They work on a contingency fee basis, meaning they only get paid if you do. It's important to act quickly to avoid losing your rights. Contact them at 1-800-YOURLAWYER (1-800-968-7529) or fill out their consultation form to have an experienced lawyer discuss your rights and claim options.

AbbVie and Biogen have voluntarily recalled Zinbryta, a multiple sclerosis drug, following reports of severe brain inflammation, including encephalitis and meningoencephalitis, affecting twelve patients and resulting in three deaths. The European Medicines Agency (EMA) has recommended suspending the drug's marketing rights due to these risks. While the U.S. FDA has not officially recalled Zinbryta, it is managing its withdrawal. Patients are advised to consult their doctors and discontinue use if necessary. Parker Waichman LLP is reviewing injury and wrongful death claims related to Zinbryta.

The Venture Catheter by Vascular Solutions Inc. has been recalled due to defects that pose serious risks, including injury or death. Parker Waichman LLP is investigating claims for those harmed by this device. The recall, classified as Class I by the FDA, affects models Venture RX, OTW, and CS, manufactured and distributed between 2015 and 2017. The defect involves excess material on the catheter tip, which can separate and enter the bloodstream. Affected individuals may be entitled to compensation and are encouraged to seek legal consultation.

Charlotte Mustard has filed a lawsuit against DePuy Orthopaedics, claiming that their ASR Hip Resurfacing System caused her severe injuries, including hip pain and heart palpitations. The implant, made of chromium and cobalt, was expected to last 20 years but failed to meet this promise. Mustard, a former athlete, alleges the implant compromised her quality of life, preventing her from competitive swimming. The ASR system was recalled in 2010 due to high failure rates, leading to over 1,000 lawsuits against DePuy and its parent company, Johnson & Johnson.

Johnson & Johnson (J&J) has been ordered to pay $55 million to a plaintiff in Missouri who developed ovarian cancer, allegedly due to long-term use of J&J's talcum powder products. The jury awarded $5 million in compensatory damages and $50 million in punitive damages after a three-week trial. This case is part of a larger legal battle, with J&J facing around 1,200 lawsuits linking their talcum powder to cancer. Despite these claims, J&J denies any connection between their products and cancer.

The Mirena IUD has been linked to uterine perforation in approximately 2 out of 1,000 users, a serious complication that may require emergency surgery. This condition can lead to infertility, infection, and other severe health issues. Allegations suggest Bayer downplayed these risks. Symptoms include abdominal pain, heavy bleeding, and fever. Women with a history of certain surgeries or who are breastfeeding are at higher risk. Legal assistance is available for affected individuals through Parker Waichman LLP, offering free evaluations for potential compensation claims.

Parker Waichman LLP is committed to advocating for clients in complex cases, focusing on protecting victims' rights and achieving significant results. They emphasize the urgency of contacting them to avoid losing legal rights. If you or a loved one experienced complications from a DePuy Pinnacle hip replacement, they urge you to call 1-800-YOURLAWYER or fill out their consultation form for a discussion on your rights and claim options with an experienced lawyer.

The State of Ohio has filed a lawsuit against several opioid drug manufacturers, including Allergan, Teva Pharmaceuticals, Johnson & Johnson, Endo Health Solutions, and Purdue Pharma. The lawsuit accuses these companies of misleading consumers and healthcare professionals about the addiction risks of their products, contributing to the opioid epidemic. Ohio seeks legal declarations of wrongdoing, injunctions against deceptive practices, compensation for public education, and reimbursements for improperly prescribed medications. The case highlights the broader issue of pharmaceutical companies overstating drug benefits while minimizing risks.